Company Dynamics

The closing meeting of the Lean Operation Management System Project (Phase I) of Dijia Pharmaceutical Group was held.

On June 22, 2021, Degas Pharmaceutical Group held a closing meeting of "Lean Operation Management System Project (Phase I)". Degas Pharmaceutical Group General Manager Wang Danqi, Production Director Jiang Lei, Superior Consulting Project Director Jiang Ying, and Superior Consulting Business Director Guo Yan attended the meeting. Degas General Manager Wang Danqi delivered a closing speech.


At the closing meeting, production director Jiang Lei reported the results of the project training. After more than 7 months of training and guidance, the lean training team has completed 125 teaching materials and 227 supporting examination questions. 112 kinds of posts have been divided. Training and certification of 117 employees and 420 person-times have been completed. In the process of project promotion, all systems and departments actively cooperated, learned and used scientific management thinking to self-examine, self-correct, summarize, and jointly completed the above work. Through this project, for the establishment of Degas production staff job training system to lay a solid foundation.

 
In the meeting, trainer Ding Hao showed the training materials. The newly compiled teaching materials adopt a unified PPT format, which clearly and vividly shows the theories and operations that should be known and understood in post work. During the exhibition process, the trainers were well-organized, clear-thinking, and full of energy, showing the level and quality that the trainers should have after systematic training, and were encouraged and recognized by the leaders present.

 
Trainer Wu Yunfei shared his experience in participating in the project at the meeting. The Dijia Lean Operation Management System project is a systematic and complex project. Everything is difficult at the beginning. The training team also had a confused, anxious, and impatient mental journey in the process of project advancement. The training team has withstood the test, completed the task, and demonstrated the spirit of perseverance and hard struggle of the Disha people. Despite the hard work of thousands of people, the trainers will become a powerful driving force for Dijia's lean operation and management.
 
Teacher Jiang Ying, Director of Premium Consulting and Training, commented on the project. From the perspective of the whole management system, Mr. Jiang Ying recognized the achievements of the project and put forward opinions and suggestions for the future development of the project. The results of this project are certainly gratifying, but the future implementation and promotion of the project will be the focus of the project. At the meeting, Mr. Jiang Ying shared the SWOT analysis of Dijia Pharmaceutical's lean operation, which provided an effective reference for the next step of the project.
   
 
 
At the meeting, General Manager Wang Danqi expressed his gratitude to the excellent consulting company for its training services, recognized the achievements of the lean operation management project, and expressed his attention and expectation to the 7 trainers trained. At the same time, new requirements were put forward for the leading cadres and front-line backbones present: first, the leading cadres should attach great importance to and fully cooperate with the follow-up implementation of the project; second, they should strictly control in accordance with the implementation plan to ensure the implementation of the rules; third, they should seek truth from facts, do not hide the problems found, and solve the problems; fourth, all staff should actively participate to create a good lean operation atmosphere.

 
 
At the end of the meeting, the company's leaders and the director of excellent consulting and training issued certification certificates to 7 trainers and took a group photo as a souvenir.


 

 
Dijia Pharmaceutical Group Co., Ltd. is a subsidiary of Disha Pharmaceutical Group. Relying on the national R & D platforms such as the national enterprise technology center and the national postdoctoral workstation of the group company, the company has established Shandong Analgesic Drug Engineering Technology Research Center and Weihai Enterprise Technology Center. The company's products strictly implement the standards of China, the European Union, the United States and Japan. The API production workshop has passed international certifications such as Japan PMDA, EU CEP, US FDA and Korea KFDA, and its quality management concept and technical strength have reached the international advanced level.